61.12 USD
NAV Per Share
Exchange Traded Funds (ETF)
Type of fund
Equity
Investment category
Biotech
Sector
USA
Investor locations
23/06/2005
Inception Date
231.64 mln USD
Total assets of the fund
0.58 %
Total Cost Ratio
Dynamic Biotech & Genome Intellidex℠ Index
Benchmark
Invesco
Provider
231.64 mln USD
Stock class assets
4 times per year
Dividend payments
-
Replication method
-
Minimum entry threshold
-
Split
US46137V7872
ISIN
PBE
Ticker
CEOJLS
CFI